EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin

Henglai Sun, Jijuan Nai, Biqi Deng, Zhen Zheng, Xuemei Chen, Chao Zhang, Huagang Sheng, Liqiao Zhu

Molecules · 05.02.2024 · 29 (3) · 731

DOI: 10.3390/molecules29030731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 05.02.2024. Verfasst von Henglai Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Angelica sinensis, Desoxycorticosterone Acetate, Liver Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, China, the Medical and Health Science and Technology Development Plan of Shandong Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present work aimed to study the feasibility of Angelica sinensis polysaccharide (ASP) as an instinctive liver targeting drug delivery carrier for oridonin (ORI) in the treatment of hepatocellular carcinoma (HCC). ASP was reacted with deoxycholic acid (DOCA) via an esterification reaction to form an ASP-DOCA conjugate. ORI-loaded ASP-DOCA nanoparticles (ORI/ASP-DOCA NPs) were prepared by the thin-film water method, and their size was about 195 nm in aqueous solution. ORI/ASP-DOCA NPs had a drug loading capacity of up to 9.2%. The release of ORI in ORI/ASP-DOCA NPs was pH-dependent, resulting in rapid decomposition and accelerated drug release at acidic pH. ORI/ASP-DOCA NPs significantly enhanced the accumulation of ORI in liver tumors through ASGPR-mediated endocytosis. In vitro results showed that ORI/ASP-DOCA NPs increased cell uptake and apoptosis in HepG2 cells, and in vivo results showed that ORI/ASP-DOCA NPs caused effective tumor suppression in H22 tumor-bearing mice compared with free ORI. In short, ORI/ASP-DOCA NPs might be a simple, feasible, safe and effective ORI nano-drug delivery system that could be used for the targeted delivery and treatment of liver tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularAngelica sinensisDesoxycorticosterone AcetateLiver NeoplasmsNanoparticlesDiterpenes, KauraneMiceAnimalsDrug CarriersPolysaccharides

Stichwörter der Autor:innen

Angelica sinensis polysaccharideantitumordrug deliverynano-carrieroridoninpH-sensitive

Substanzen

oridoninDesoxycorticosterone AcetateDrug CarriersPolysaccharidesDiterpenes, Kaurane

Autor:innen und Institutionen

  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

Förderung

  • Shandong Provincial Natural Science Foundation, China
  • the Medical and Health Science and Technology Development Plan of Shandong Province, China

Zitieren

APA

Sun, H., Nai, J., Deng, B., Zheng, Z., Chen, X., Zhang, C., Sheng, H., & Zhu, L. (2024). Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin. Molecules, 29(3), 731. https://doi.org/10.3390/molecules29030731

Vancouver

Sun H, Nai J, Deng B, Zheng Z, Chen X, Zhang C, et al. Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin. Molecules. 2024;29(3):731. doi:10.3390/molecules29030731

BibTeX
@article{Sun2024,
  author = {Sun, Henglai and Nai, Jijuan and Deng, Biqi and Zheng, Zhen and Chen, Xuemei and Zhang, Chao and Sheng, Huagang and Zhu, Liqiao},
  title = {Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {3},
  pages = {731},
  doi = {10.3390/molecules29030731}
}
Kostenlos starten →